To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.
The subjects sign the informed consent voluntarily and can complete the test according to the protocol requirements;
Age 18-85 years old, male or female;
Clinically diagnosed as malignant tumor, diagnostic criteria refer to biopsy or other imaging such as CT and MRI;
ECOG score is 0-3 points;
Patients with a history or allergic constitution to any component of the developer, including alcohol;
pregnant or lactating women;
Patients with mental illness or related history;
Patients who cannot or cannot undergo a PET/CT scan;